ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 35 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | +2.4% | 61,973 | +2.7% | 0.00% | – |
| Q2 2023 | $83 | +9.2% | 60,373 | +87.7% | 0.00% | – |
| Q1 2023 | $76 | +11.8% | 32,173 | +8.4% | 0.00% | – |
| Q4 2022 | $68 | -99.9% | 29,673 | -6.9% | 0.00% | – |
| Q3 2022 | $88,000 | +11.4% | 31,873 | -0.9% | 0.00% | – |
| Q2 2022 | $79,000 | +8.2% | 32,173 | +74.2% | 0.00% | – |
| Q1 2022 | $73,000 | +21.7% | 18,473 | +35.1% | 0.00% | – |
| Q4 2021 | $60,000 | -75.5% | 13,673 | -65.5% | 0.00% | – |
| Q3 2021 | $245,000 | +46.7% | 39,663 | +87.9% | 0.00% | – |
| Q2 2021 | $167,000 | -42.2% | 21,107 | -22.0% | 0.00% | – |
| Q1 2021 | $289,000 | – | 27,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |